Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10327)
All Articles published online
|
Publishing Process of This Article
|
Oct 28, 2015 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gallego-Durán R, Romero-Gómez M. Epigenetic mechanisms in non-alcoholic fatty liver disease: An emerging field. World J Hepatol 2015; 7(24): 2497-2502 [PMID: 26523202 DOI: 10.4254/wjh.v7.i24.2497] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i24/2497.htm |
| Number | Citing Articles |
| 1 |
Vanessa D. de Mello, Ashok Matte, Alexander Perfilyev, Ville Männistö, Tina Rönn, Emma Nilsson, Pirjo Käkelä, Charlotte Ling, Jussi Pihlajamäki. Human liver epigenetic alterations in non-alcoholic steatohepatitis are related to insulin action. Epigenetics 2017; 12(4): 287 doi: 10.1080/15592294.2017.1294305
|
| 2 |
J. Samael Rodríguez-Sanabria, Rebeca Escutia-Gutiérrez, Rebeca Rosas-Campos, Juan S. Armendáriz-Borunda, Ana Sandoval-Rodríguez. An Update in Epigenetics in Metabolic-Associated Fatty Liver Disease. Frontiers in Medicine 2022; 8 doi: 10.3389/fmed.2021.770504
|
| 3 |
Reham Mohammed Dawood, Ghada Maher Salum, Mai Abd El-Meguid, Basma EL-sayed Fotouh. Molecular Insights of Nonalcoholic Fatty Liver Disease Pathogenesis. Journal of Interferon & Cytokine Research 2024; 44(3): 111 doi: 10.1089/jir.2023.0162
|
| 4 |
Anıl Delik, Hikmet Akkız, Sadık Dinçer. The effect of PNPLA3 polymorphism as gain in function mutation in the pathogenesis of non-alcoholic fatty liver disease. Indian Journal of Gastroenterology 2020; 39(1): 84 doi: 10.1007/s12664-020-01026-x
|
| 5 |
Sabrina Campisano, Anabela La Colla, Stella M. Echarte, Andrea N. Chisari. Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseases. Nutrition Research Reviews 2019; 32(1): 128 doi: 10.1017/S0954422418000239
|
| 6 |
Xinting Pan, Yunli Wu, Hewei Peng, Xiaoling Cai, Zhijian Hu, Xu Lin, Xian-e Peng. Genome-wide DNA methylation profiling in nonalcoholic fatty liver reveals predictive aberrant methylation in PRKCE and SEC14L3 promoters. Digestive and Liver Disease 2022; 54(4): 521 doi: 10.1016/j.dld.2021.05.013
|
| 7 |
Rodrigo Vieira Costa Lima, José Tadeu Stefano, Fernanda de Mello Malta, João Renato Rebello Pinho, Flair José Carrilho, Marco Arrese, Claudia P. Oliveira. Ability of a Combined FIB4/miRNA181a Score to Predict Significant Liver Fibrosis in NAFLD Patients. Biomedicines 2021; 9(12): 1751 doi: 10.3390/biomedicines9121751
|
| 8 |
Amar Mahgoub, Clifford Steer. MicroRNAs in the Evaluation and Potential Treatment of Liver Diseases. Journal of Clinical Medicine 2016; 5(5): 52 doi: 10.3390/jcm5050052
|
| 9 |
Doris Kaltenecker, Madeleine Themanns, Kristina M. Mueller, Katrin Spirk, Tobias Suske, Olaf Merkel, Lukas Kenner, Andreia Luís, Andrey Kozlov, Johannes Haybaeck, Mathias Müller, Xiaonan Han, Richard Moriggl. Hepatic growth hormone - JAK2 - STAT5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progression. Cytokine 2019; 124: 154569 doi: 10.1016/j.cyto.2018.10.010
|
| 10 |
Xiao-Fei Peng, Shi-Feng Huang, Ling-Juan Chen, Lingqing Xu, Wen-Chu Ye. Targeting epigenetics and lncRNAs in liver disease: From mechanisms to therapeutics. Pharmacological Research 2021; 172: 105846 doi: 10.1016/j.phrs.2021.105846
|
| 11 |
Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová, Ladislav Turecký. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD. International Journal of Environmental Research and Public Health 2019; 16(19): 3570 doi: 10.3390/ijerph16193570
|
| 12 |
Naga Swetha Samji, Rajanshu Verma, Krishna Chaitanya Keri, Ashwani K. Singal, Aijaz Ahmed, Mary Rinella, David Bernstein, Manal F. Abdelmalek, Sanjaya K. Satapathy. Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges. Digestive Diseases and Sciences 2019; 64(12): 3413 doi: 10.1007/s10620-019-05716-1
|
| 13 |
Manuel Suárez, Noemí Boqué, Josep Del Bas, Jordi Mayneris-Perxachs, Lluís Arola, Antoni Caimari. Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease. Nutrients 2017; 9(10): 1052 doi: 10.3390/nu9101052
|
| 14 |
Abdullah S. Shatoor, Suliman Al Humayed, Hussain M. Almohiy. Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2. Journal of Physiology and Biochemistry 2022; 78(1): 151 doi: 10.1007/s13105-021-00850-9
|
| 15 |
Mario Vailati-Riboni, Johan S. Osorio, Erminio Trevisi, Daniel Luchini, Juan J. Loor. Supplemental Smartamine M in higher-energy diets during the prepartal period improves hepatic biomarkers of health and oxidative status in Holstein cows. Journal of Animal Science and Biotechnology 2017; 8(1) doi: 10.1186/s40104-017-0147-7
|
| 16 |
Na Wu, Fan Yuan, Siran Yue, Fengyan Jiang, Decheng Ren, Liangjie Liu, Yan Bi, Zhenming Guo, Lei Ji, Ke Han, Xiao Yang, Mofan Feng, Kai Su, Fengping Yang, Xi Wu, Qing Lu, Xingwang Li, Ruirui Wang, Baocheng Liu, Shenglong Le, Yi Shi, Guang He. Effect of exercise and diet intervention in NAFLD and NASH via GAB2 methylation. Cell & Bioscience 2021; 11(1) doi: 10.1186/s13578-021-00701-6
|
| 17 |
Francesco Valentini, Giulia Rocchi, Umberto Vespasiani-Gentilucci, Michele Pier Luca Guarino, Annamaria Altomare, Simone Carotti. The Origins of NAFLD: The Potential Implication of Intrauterine Life and Early Postnatal Period. Cells 2022; 11(3): 562 doi: 10.3390/cells11030562
|
| 18 |
Reda Albadawy, Sara H. A. Agwa, Eman Khairy, Maha Saad, Naglaa El Touchy, Mohamed Othman, Mohamed El Kassas, Marwa Matboli. Circulatory Endothelin 1-Regulating RNAs Panel: Promising Biomarkers for Non-Invasive NAFLD/NASH Diagnosis and Stratification: Clinical and Molecular Pilot Study. Genes 2021; 12(11): 1813 doi: 10.3390/genes12111813
|
| 19 |
Sierra D Riegl, Cassie Starnes, Dereje D Jima, Marine Baptissart, Anna Mae Diehl, Scott M Belcher, Michael Cowley. The imprinted geneZac1regulates steatosis in developmental cadmium-induced nonalcoholic fatty liver disease. Toxicological Sciences 2023; 191(1): 34 doi: 10.1093/toxsci/kfac106
|
| 20 |
Xiaoyan Qi, Jinping Lai. Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH). International Journal of Molecular Sciences 2022; 23(21): 13501 doi: 10.3390/ijms232113501
|
| 21 |
Fung Zhao. Obesity, Fatty Liver and Liver Cancer. Advances in Experimental Medicine and Biology 2018; 1061: 79 doi: 10.1007/978-981-10-8684-7_7
|
| 22 |
Jeongeun Hyun, Youngmi Jung. DNA Methylation in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2020; 21(21): 8138 doi: 10.3390/ijms21218138
|
| 23 |
Rai Ajit K. Srivastava. Life-style-induced metabolic derangement and epigenetic changes promote diabetes and oxidative stress leading to NASH and atherosclerosis severity. Journal of Diabetes & Metabolic Disorders 2018; 17(2): 381 doi: 10.1007/s40200-018-0378-y
|
| 24 |
Eckhard Klieser, Christian Mayr, Tobias Kiesslich, Till Wissniowski, Pietro Di Fazio, Daniel Neureiter, Matthias Ocker. The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications. International Journal of Molecular Sciences 2019; 20(21): 5266 doi: 10.3390/ijms20215266
|
| 25 |
Anıl Delik, Sadık Dinçer, Hikmet Akkız. The role of genetic and epigenetic factors in non alcoholic fatty liver disease (NAFLD) pathogenesis. Meta Gene 2020; 24: 100647 doi: 10.1016/j.mgene.2020.100647
|
| 26 |
Marine Baptissart, Christine M. Bradish, Brie S. Jones, Evan Walsh, Jesse Tehrani, Vicmarie Marrero‐Colon, Sanya Mehta, Dereje D. Jima, Seh Hoon Oh, Anna Mae Diehl, Tiffany Fougeray, Hervé Guillou, Michael Cowley. Zac1 and the Imprinted Gene Network program juvenile NAFLD in response to maternal metabolic syndrome. Hepatology 2022; 76(4): 1090 doi: 10.1002/hep.32363
|
| 27 |
Yu Yuan Li, Dan Tang, Yan Lei Du, Chuang Yu Cao, Yu Qiang Nie, Jie Cao, Yong Jian Zhou. Fatty liver mediated by peroxisome proliferator‐activated receptor‐α DNA methylation can be reversed by a methylation inhibitor and curcumin. Journal of Digestive Diseases 2018; 19(7): 421 doi: 10.1111/1751-2980.12610
|
| 28 |
Kubanich A. Aitbaev, Ilkhom T. Murkamilov, Zhamila A. Murkamilova, Viktor V. Fomin, Indira O. Kudaibergenova, Furkat A. Yusupov. Non-alcoholic fatty liver disease: an epigenetic view of pathogenesis and a new treatment options. Experimental and Clinical Gastroenterology 2022; (7): 171 doi: 10.31146/1682-8658-ecg-203-7-171-176
|
| 29 |
Stephanie R. Wesolowski, Karim C. El Kasmi, Karen R. Jonscher, Jacob E. Friedman. Developmental origins of NAFLD: a womb with a clue. Nature Reviews Gastroenterology & Hepatology 2017; 14(2): 81 doi: 10.1038/nrgastro.2016.160
|
| 30 |
Joseph Boachie, Antonysunil Adaikalakoteswari, Jinous Samavat, Ponnusamy Saravanan. Low Vitamin B12 and Lipid Metabolism: Evidence from Pre-Clinical and Clinical Studies. Nutrients 2020; 12(7): 1925 doi: 10.3390/nu12071925
|
| 31 |
Mayada Metwally, Mohammed Eslam, Jacob George. Genetic and Epigenetic Associations of NAFLD: Focus on Clinical Decision Making. Current Hepatology Reports 2017; 16(4): 335 doi: 10.1007/s11901-017-0372-8
|
| 32 |
Letícia F Ramos, Caio M Silva, Camila C Pansa, Karen C M Moraes. Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liver. Expert Review of Gastroenterology & Hepatology 2021; 15(1): 25 doi: 10.1080/17474124.2020.1820321
|
| 33 |
Niki Katsiki, Dimitri P. Mikhailidis, Christos S. Mantzoros. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism 2016; 65(8): 1109 doi: 10.1016/j.metabol.2016.05.003
|
| 34 |
Guangrong Dai, Pengfei Liu, Xiaomei Li, Xiaoyan Zhou, Shuixiang He. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity. Medicine 2019; 98(7): e14324 doi: 10.1097/MD.0000000000014324
|
| 35 |
Jooho Lee, Yuri Kim, Simonetta Friso, Sang-Woon Choi. Epigenetics in non-alcoholic fatty liver disease. Molecular Aspects of Medicine 2017; 54: 78 doi: 10.1016/j.mam.2016.11.008
|
| 36 |
Shuo Wang, Jieyun Song, Yide Yang, Yining Zhang, Nitesh V. Chawla, Jun Ma, Haijun Wang. Interaction between obesity and the Hypoxia Inducible Factor 3 Alpha Subunit rs3826795 polymorphism in relation with plasma alanine aminotransferase. BMC Medical Genetics 2017; 18(1) doi: 10.1186/s12881-017-0437-0
|